The escalating incidence of neurodegenerative diseases, including Alzheimer’s, Parkinson’s, and Huntington’s, poses a significant global health challenge, prompting an urgent need for effective therapeutic interventions. Neuroprotective phytomedicines, derived from various medicinal plants, represent a promising avenue for the development of novel treatments. These phytomedicines are rich in bioactive compounds that may confer neuroprotection through multiple mechanisms, including the modulation of oxidative stress, anti-inflammatory pathways, and the inhibition of neuronal apoptosis. Recent studies have identified several plant-derived compounds, such as curcumin, resveratrol, and ginkgo biloba extract, as having potential neuroprotective properties. For instance, curcumin has demonstrated the ability to reduce amyloid-beta aggregation in Alzheimer’s models, while resveratrol has shown promise in enhancing mitochondrial function and neurogenesis. Furthermore, Ginkgo biloba has been reported to improve cognitive function by increasing cerebral blood flow and exhibiting antioxidant effects. Despite the therapeutic potential, the development of neuroprotective phytomedicines faces several challenges. Variability in the phytochemical composition of plant extracts can lead to inconsistent therapeutic effects, complicating standardization efforts. Moreover, several bioactive compounds exhibit low bioavailability, which limits their efficacy in clinical settings. Regulatory hurdles and the necessity for rigorous clinical evidence also present significant barriers to the commercialization of these phytomedicines. To overcome these challenges, innovative strategies such as advanced extraction techniques, nanotechnology-based formulations, and targeted delivery systems are essential. Additionally, comprehensive clinical trials that investigate the pharmacokinetics, safety, and efficacy of these compounds are crucial for substantiating their therapeutic claims. Addressing these multifaceted challenges will be pivotal in unlocking the full therapeutic potential of neuroprotective phytomedicines, paving the way for effective treatments for neurodegenerative diseases.